CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.

A visual look at Wall Street's Santa Claus rallies since 2000, even as such a rally comes under pressure on Thursday. Read ...

The NASDAQ-100 is currently trading at a scorching hot 38 times earnings. It has been said that the Magnificent Seven stocks ...

AliExpress International and South Korea-based E-Mart's e-commerce platform Gmarket are forming a 50-50 joint venture in ...

Invest in undervalued Delta Air Lines with a strong financial position, mitigated risks, and significant growth potential in ...

Canadian Solar faces near-term challenges but has long-term growth potential, highlighting estimated fair value and future ...

Small Cap Opportunity Fund A Shares posted a return of 5.25% in the third quarter of 2024. As we were reminded in August and ...

Permian Resources Corp is a leader in the U.S. oil field, showing strong cash flow, operational excellence, and a focus on ...

While financial assets generally were strong in the third quarter, volatility trended higher as markets continued to be ...

Gap is on the rise, with strong Q3 results signaling a turnaround. It trades at just 11.9x fwd P/E, well below the industry ...

Read an update on the impact of a shifting yield curve on bond markets, potential inflation, and a trade opportunity in the ...

Nokian grew underlying earnings regardless prior to the rapid production ramp-up. Its Romanian factory will start production ...